You are here

  • Home
  • Archive
  • Volume 67, Issue 8
  • Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

Citation Tools

Article menu

Download PDFPDF

Extended report
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Schiff M, Keiserman M, Codding C, et al
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
Annals of the Rheumatic Diseases 2008;67:1096-1103.